The impact of sarcopenia and myosteatosis on postoperative outcomes and 5-year survival in curatively operated colorectal cancer patients – A retrospective register study
- 1 September 2020
- journal article
- research article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 46 (9) , 1656-1662
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Muscoloskeletal aging, sarcopenia and cancerJournal of Geriatric Oncology, 2019
- Sarcopenia predicts poor postoperative outcome in elderly patients with lung cancerGeneral Thoracic and Cardiovascular Surgery, 2019
- Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methodsInternational Journal of Cancer, 2018
- Low muscle attenuation is a prognostic factor for survival in metastatic breast cancer patients treated with first line palliative chemotherapyThe Breast, 2017
- Differentiating Sarcopenia and Cachexia Among Patients With CancerNutrition in Clinical Practice, 2016
- Sarcopenia and sarcopenic obesityThe Korean Journal of Internal Medicine, 2016
- Low skeletal muscle radiation attenuation and visceral adiposity are associated with overall survival and surgical site infections in patients with pancreatic cancerJournal of Cachexia, Sarcopenia and Muscle, 2016
- Skeletal muscle mass and quality as risk factors for postoperative outcome after open colon resection for cancerInternational Journal of Colorectal Disease, 2016
- Low Muscularity and Myosteatosis Is Related to the Host Systemic Inflammatory Response in Patients Undergoing Surgery for Colorectal CancerAnnals of Surgery, 2016
- The role of body composition evaluation by computerized tomography in determining colorectal cancer treatment outcomes: A systematic reviewEuropean Journal of Surgical Oncology, 2015